2026年11月3日星期二
M
Rekod Semesta
Berita Pantas Global
Working collaboratively to fight scams in Asia Pacific— Google 官方博客Why PC makers are turning back to China— 日经 Nikkei AsiaAustralia gold miner Northern Star lifts output amid investor pressure— 日经 Nikkei AsiaMalaysia transport minister still plans to quit, says megaprojects safe— 日经 Nikkei AsiaApple's new CEO delivers first earnings as sales hit record— 日经 Nikkei AsiaJapan's Aisin develops new type of AI chip that cuts energy use 98%— 日经 Nikkei AsiaEthics drive Wardah to pinnacle of Southeast Asia's beauty brands— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei AsiaWorking collaboratively to fight scams in Asia Pacific— Google 官方博客Why PC makers are turning back to China— 日经 Nikkei AsiaAustralia gold miner Northern Star lifts output amid investor pressure— 日经 Nikkei AsiaMalaysia transport minister still plans to quit, says megaprojects safe— 日经 Nikkei AsiaApple's new CEO delivers first earnings as sales hit record— 日经 Nikkei AsiaJapan's Aisin develops new type of AI chip that cuts energy use 98%— 日经 Nikkei AsiaEthics drive Wardah to pinnacle of Southeast Asia's beauty brands— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei Asia

Neoadjuvant apalutamide for high-risk prostate cancer

Sumber Nature 医学研究7 hari lalu
Ringkasan kandungan

Laman ini hanya menyediakan indeks tajuk dan ringkasan, kandungan penuh dan hak cipta adalah milik pihak penerbit asal, sila klik pautan asal untuk membaca.

Pergi ke artikel asal
Saluran berkaitan
Kesihatan
Kawasan berkaitan
Perspektif global
Bahasa teks asal
English
Nombor entri
health-120173df

Comments 0 comments

No comments yet. Be the first.

Neoadjuvant apalutamide for high-risk prostate cancer · Rekod Semesta